Summary of Significant Accounting Policies - Schedule of Disaggregated By Revenue (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Disaggregation of Revenue [Line Items]
Total revenue	$ 982,021	$ 739,016	$ 563,948
Oncology
Disaggregation of Revenue [Line Items]
Total revenue	683,595	542,827	403,876
Biopharma and data
Disaggregation of Revenue [Line Items]
Total revenue	210,132	177,579	136,351
Screening
Disaggregation of Revenue [Line Items]
Total revenue	79,732	5,124	0
Licensing and other
Disaggregation of Revenue [Line Items]
Total revenue	$ 8,562	$ 13,486	$ 23,721